These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26414176)

  • 1. Development of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus Exercises.
    de Lautour H; Taylor WJ; Adebajo A; Alten R; Burgos-Vargas R; Chapman P; Cimmino MA; da Rocha Castelar Pinheiro G; Day R; Harrold LR; Helliwell P; Janssen M; Kerr G; Kavanaugh A; Khanna D; Khanna PP; Lin C; Louthrenoo W; McCarthy G; Vazquez-Mellado J; Mikuls TR; Neogi T; Ogdie A; Perez-Ruiz F; Schlesinger N; Ralph Schumacher H; Scirè CA; Singh JA; Sivera F; Slot O; Stamp LK; Tausche AK; Terkeltaub R; Uhlig T; van de Laar M; White D; Yamanaka H; Zeng X; Dalbeth N
    Arthritis Care Res (Hoboken); 2016 May; 68(5):667-72. PubMed ID: 26414176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent validity of provisional remission criteria for gout: a dual-energy CT study.
    Dalbeth N; Frampton C; Fung M; Baumgartner S; Nicolaou S; Choi HK
    Arthritis Res Ther; 2019 Jun; 21(1):150. PubMed ID: 31227018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in measurement instruments for acute and chronic gout studies.
    Grainger R; Taylor WJ; Dalbeth N; Perez-Ruiz F; Singh JA; Waltrip RW; Schlesinger N; Evans R; Edwards NL; Sivera F; Diaz-Torne C; MacDonald PA; McQueen FM; Schumacher HR
    J Rheumatol; 2009 Oct; 36(10):2346-55. PubMed ID: 19820224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome domains for studies of acute and chronic gout.
    Schumacher HR; Taylor W; Edwards L; Grainger R; Schlesinger N; Dalbeth N; Sivera F; Singh J; Evans R; Waltrip RW; Diaz-Torne C; MacDonald P; McQueen F; Perez-Ruiz F
    J Rheumatol; 2009 Oct; 36(10):2342-5. PubMed ID: 19820223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are Target Urate and Remission Possible in Severe Gout? A Five-year Cohort Study.
    Alvarado-de la Barrera C; López-López CO; Álvarez-Hernández E; Peláez-Ballestas I; Gómez-Ruiz C; Burgos-Vargas R; Vázquez-Mellado J
    J Rheumatol; 2020 Jan; 47(1):132-139. PubMed ID: 31043541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gout, Hyperuricemia, and Crystal-Associated Disease Network Consensus Statement Regarding Labels and Definitions for Disease Elements in Gout.
    Bursill D; Taylor WJ; Terkeltaub R; Kuwabara M; Merriman TR; Grainger R; Pineda C; Louthrenoo W; Edwards NL; Andrés M; Vargas-Santos AB; Roddy E; Pascart T; Lin CT; Perez-Ruiz F; Tedeschi SK; Kim SC; Harrold LR; McCarthy G; Kumar N; Chapman PT; Tausche AK; Vazquez-Mellado J; Gutierrez M; da Rocha Castelar-Pinheiro G; Richette P; Pascual E; Fisher MC; Burgos-Vargas R; Robinson PC; Singh JA; Jansen TL; Saag KG; Slot O; Uhlig T; Solomon DH; Keenan RT; Scire CA; Biernat-Kaluza E; Dehlin M; Nuki G; Schlesinger N; Janssen M; Stamp LK; Sivera F; Reginato AM; Jacobsson L; Lioté F; Ea HK; Rosenthal A; Bardin T; Choi HK; Hershfield MS; Czegley C; Choi SJ; Dalbeth N
    Arthritis Care Res (Hoboken); 2019 Mar; 71(3):427-434. PubMed ID: 29799677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A modified Delphi exercise to determine the extent of consensus with OMERACT outcome domains for studies of acute and chronic gout.
    Taylor WJ; Schumacher HR; Baraf HS; Chapman P; Stamp L; Doherty M; McQueen F; Dalbeth N; Schlesinger N; Furst DE; Vazquez-Mellado J; Becker MA; Kavanaugh A; Louthrenoo W; Bardin T; Khanna D; Simon LS; Yamanaka H; Choi HK; Zeng X; Strand V; Grainger R; Clegg D; Singh JA; Diaz-Torne C; Boers M; Gow P; Barskova VG
    Ann Rheum Dis; 2008 Jun; 67(6):888-91. PubMed ID: 18055475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do patient preferences for core outcome domains for chronic gout studies support the validity of composite response criteria?
    Taylor WJ; Brown M; Aati O; Weatherall M; Dalbeth N
    Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1259-64. PubMed ID: 23335569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a patient-reported outcome measure of tophus burden: the Tophus Impact Questionnaire (TIQ-20).
    Aati O; Taylor WJ; Siegert RJ; Horne A; House ME; Tan P; Drake J; Stamp LK; Dalbeth N
    Ann Rheum Dis; 2015 Dec; 74(12):2144-50. PubMed ID: 25114061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward a valid definition of gout flare: results of consensus exercises using Delphi methodology and cognitive mapping.
    Taylor WJ; Shewchuk R; Saag KG; Schumacher HR; Singh JA; Grainger R; Edwards NL; Bardin T; Waltrip RW; Simon LS; Burgos-Vargas R
    Arthritis Rheum; 2009 Apr; 61(4):535-43. PubMed ID: 19333981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gout Remission as a Goal of Urate-Lowering Therapy: A Critical Review.
    Tabi-Amponsah AD; Stewart S; Hosie G; Stamp LK; Taylor WJ; Dalbeth N
    Pharmaceuticals (Basel); 2023 May; 16(6):. PubMed ID: 37375727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International Consensus for ultrasound lesions in gout: results of Delphi process and web-reliability exercise.
    Gutierrez M; Schmidt WA; Thiele RG; Keen HI; Kaeley GS; Naredo E; Iagnocco A; Bruyn GA; Balint PV; Filippucci E; Mandl P; Kane D; Pineda C; Delle Sedie A; Hammer HB; Christensen R; D'Agostino MA; Terslev L;
    Rheumatology (Oxford); 2015 Oct; 54(10):1797-805. PubMed ID: 25972391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum urate as a soluble biomarker in chronic gout-evidence that serum urate fulfills the OMERACT validation criteria for soluble biomarkers.
    Stamp LK; Zhu X; Dalbeth N; Jordan S; Edwards NL; Taylor W
    Semin Arthritis Rheum; 2011 Jun; 40(6):483-500. PubMed ID: 21056459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uricosuric medications for chronic gout.
    Kydd AS; Seth R; Buchbinder R; Edwards CJ; Bombardier C
    Cochrane Database Syst Rev; 2014 Nov; (11):CD010457. PubMed ID: 25392987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome evaluations in gout.
    Schumacher HR; Taylor W; Joseph-Ridge N; Perez-Ruiz F; Chen LX; Schlesinger N; Khanna D; Furst DE; Becker MA; Dalbeth N; Edwards NL
    J Rheumatol; 2007 Jun; 34(6):1381-5. PubMed ID: 17552064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does starting allopurinol prolong acute treated gout? A randomized clinical trial.
    Hill EM; Sky K; Sit M; Collamer A; Higgs J
    J Clin Rheumatol; 2015 Apr; 21(3):120-5. PubMed ID: 25807090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout.
    Bursill D; Taylor WJ; Terkeltaub R; Abhishek A; So AK; Vargas-Santos AB; Gaffo AL; Rosenthal A; Tausche AK; Reginato A; Manger B; Sciré C; Pineda C; van Durme C; Lin CT; Yin C; Albert DA; Biernat-Kaluza E; Roddy E; Pascual E; Becce F; Perez-Ruiz F; Sivera F; Lioté F; Schett G; Nuki G; Filippou G; McCarthy G; da Rocha Castelar Pinheiro G; Ea HK; Tupinambá HA; Yamanaka H; Choi HK; Mackay J; ODell JR; Vázquez Mellado J; Singh JA; Fitzgerald JD; Jacobsson LTH; Joosten L; Harrold LR; Stamp L; Andrés M; Gutierrez M; Kuwabara M; Dehlin M; Janssen M; Doherty M; Hershfield MS; Pillinger M; Edwards NL; Schlesinger N; Kumar N; Slot O; Ottaviani S; Richette P; MacMullan PA; Chapman PT; Lipsky PE; Robinson P; Khanna PP; Gancheva RN; Grainger R; Johnson RJ; Te Kampe R; Keenan RT; Tedeschi SK; Kim S; Choi SJ; Fields TR; Bardin T; Uhlig T; Jansen T; Merriman T; Pascart T; Neogi T; Klück V; Louthrenoo W; Dalbeth N
    Ann Rheum Dis; 2019 Nov; 78(11):1592-1600. PubMed ID: 31501138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and First Validation of a Disease Activity Score for Gout.
    Scirè CA; Carrara G; Viroli C; Cimmino MA; Taylor WJ; Manara M; Govoni M; Salaffi F; Punzi L; Montecucco C; Matucci-Cerinic M; Minisola G;
    Arthritis Care Res (Hoboken); 2016 Oct; 68(10):1530-7. PubMed ID: 26815286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome measurements in scleroderma: results from a delphi exercise.
    Gazi H; Pope JE; Clements P; Medsger TA; Martin RW; Merkel PA; Kahaleh B; Wollheim FA; Baron M; Csuka ME; Emery P; Belch JF; Hayat S; Lally EV; Korn JH; Czirjak L; Herrick A; Voskuyl AE; Bruehlmann P; Inanc M; Furst DE; Black C; Ellman MH; Moreland LW; Rothfield NF; Hsu V; Mayes M; McKown KM; Krieg T; Siebold JR
    J Rheumatol; 2007 Mar; 34(3):501-9. PubMed ID: 17299843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Patient Experience of Gout Remission: A Qualitative Study.
    Tabi-Amponsah AD; Stewart S; Hosie G; Horne A; Dalbeth N
    ACR Open Rheumatol; 2023 Aug; 5(8):399-406. PubMed ID: 37401117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.